download
print
% Change:
Volume:
52-Week High:
52-Week Low:

EVENTS & PRESENTATIONS

Goldman Sachs 44th Annual Global Healthcare Conference

Learn More ›

BofA Securities 2023 Health Care Conference

Past Events ›

Alnylam Pharmaceuticals Q1 2023 Earnings Conference Call

Past Events ›

View all events and presentations ›
container-970 d-flex flex-1

2022 Annual Report

Download

2023 Proxy Statement

Download

capella

Investor & Scientific Presentations

Explore Capella ›

Investor Toolkit

Quarterly Earnings Presentation - Icon

Q1 2023 Earnings Presentation VIEW PDF ›

10-K - Icon

Latest Form 10-K VIEW PDF ›

10-Q - Icon

Latest Form10-Q VIEW PDF ›

sec-icon

SEC
Filings VIEW All ›

sec-icon

Corporate Responsibility VIEW PDF ›

View all resources and documents ›

Discover Our Commitment to Patients, Employees, and Our Communities

Corporate Responsibility ›

PRESS RELEASES

Alnylam to Webcast Presentation at Goldman Sachs 44th Annual Global Healthcare Conference

Learn More ›

Alnylam Presents 18-Month Results from the APOLLO-B Phase 3 Study of Patisiran in Patients with ATTR Amyloidosis with Cardiomyopathy

Learn More ›

Alnylam Pharmaceuticals Reports First Quarter 2023 Financial Results and Highlights Recent Period Activity

Learn More ›

View all press releases ›